Jun 15, 2026 12:00PM
Jun 9, 2026 04:30PM
Jun 9, 2026 04:30PM
Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM
Feb 10, 2026 04:50AM
Feb 10, 2026 03:15AM U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
Jan 16, 2024 08:17AM
Nov 8, 2023 05:57PM
Nov 8, 2023 05:54PM
May 25, 2023 04:31PM
May 25, 2023 04:30PM
Oct 28, 2021 02:15AM
Sep 21, 2021 08:06AM Mirum Pharmaceuticals (MIRM), Takeda (TAK) Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan
Sep 21, 2021 08:00AM
Apr 27, 2021 05:30PM
Feb 24, 2020 08:00AM

15,464 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All